Health
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity – NewsMaker
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity
Vancouver, BC, Nov 2, 2020 – (ACN Newswire) – BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in haptenized protein vaccine research and development, announced today that it has filed a Provisional Patent Application with the U.S. Patent and Trademark Office entitled METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE related to the potential development of a diagnostic for evaluating the presence or absence of a T-cell immune response to SARS-CoV-2,…
-
Business19 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News19 hours agoQueensland’s nurses and midwives ramp up industrial action as pay negotiations break down
-
Noosa News20 hours agoBroncos staffer who guided Mam through crash crisis admits to drink-driving
-
Noosa News21 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal